Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Geradts

Showing results (31-40 of 58) with videos related to

Pageof 6
Sort By:
Oncogene|October 30, 1998
RET cooperates with RB/p53 inactivation in a somatic multi-step model for murine thyroid cancerA B Coxon, J M Ward, J Geradts, et al.
British Journal of Cancer|June 22, 1999
G1 checkpoint protein and p53 abnormalities occur in most invasive transitional cell carcinomas of the urinary bladderG A Niehans, R A Kratzke, M K Froberg, et al.
The American Journal of Pathology|April 18, 1998
Nasopharyngeal carcinomas frequently lack the p16/MTS1 tumor suppressor protein but consistently express the retinoblastoma gene productM L Gulley, J M Nicholls, B G Schneider, et al.
Journal of Clinical Pathology|August 27, 2002
Epstein-Barr virus in gastric adenocarcinomas: association with ethnicity and CDKN2A promoter methylationQ N Vo, J Geradts, M L Gulley, et al.
Cancer Research|February 24, 2001
Aberrant promoter methylation of multiple genes in non-small cell lung cancersS Zöchbauer-Müller, K M Fong, A K Virmani, et al.
Cancer Research|October 28, 1999
Abnormal Fhit expression in malignant and premalignant lesions of the cervixM J Birrer, D Hendricks, J Farley, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 12, 2002
Environmental factors in relation to breast cancer characterized by p53 protein expressionHelena Furberg, R C Millikan, J Geradts, et al.
Molecular Carcinogenesis|February 1, 1996
Molecular and immunochemical analyses of RB1 and cyclin D1 in human ductal pancreatic carcinomas and cell linesL Huang, D Lang, J Geradts, et al.
Journal of the National Cancer Institute|December 20, 1995
Immunohistochemical analysis of the p16INK4 cyclin-dependent kinase inhibitor in malignant mesotheliomaR A Kratzke, G A Otterson, C E Lincoln, et al.
Breast Cancer Research and Treatment|July 1, 1995
The Carolina Breast Cancer Study: integrating population-based epidemiology and molecular biologyB Newman, P G Moorman, R Millikan, et al.
Pageof 6

Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
Oncogene|October 30, 1998
RET cooperates with RB/p53 inactivation in a somatic multi-step model for murine thyroid cancerA B Coxon, J M Ward, J Geradts, et al.
British Journal of Cancer|June 22, 1999
G1 checkpoint protein and p53 abnormalities occur in most invasive transitional cell carcinomas of the urinary bladderG A Niehans, R A Kratzke, M K Froberg, et al.
The American Journal of Pathology|April 18, 1998
Nasopharyngeal carcinomas frequently lack the p16/MTS1 tumor suppressor protein but consistently express the retinoblastoma gene productM L Gulley, J M Nicholls, B G Schneider, et al.
Journal of Clinical Pathology|August 27, 2002
Epstein-Barr virus in gastric adenocarcinomas: association with ethnicity and CDKN2A promoter methylationQ N Vo, J Geradts, M L Gulley, et al.
Cancer Research|February 24, 2001
Aberrant promoter methylation of multiple genes in non-small cell lung cancersS Zöchbauer-Müller, K M Fong, A K Virmani, et al.
Cancer Research|October 28, 1999
Abnormal Fhit expression in malignant and premalignant lesions of the cervixM J Birrer, D Hendricks, J Farley, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 12, 2002
Environmental factors in relation to breast cancer characterized by p53 protein expressionHelena Furberg, R C Millikan, J Geradts, et al.
Molecular Carcinogenesis|February 1, 1996
Molecular and immunochemical analyses of RB1 and cyclin D1 in human ductal pancreatic carcinomas and cell linesL Huang, D Lang, J Geradts, et al.
Journal of the National Cancer Institute|December 20, 1995
Immunohistochemical analysis of the p16INK4 cyclin-dependent kinase inhibitor in malignant mesotheliomaR A Kratzke, G A Otterson, C E Lincoln, et al.
Breast Cancer Research and Treatment|July 1, 1995
The Carolina Breast Cancer Study: integrating population-based epidemiology and molecular biologyB Newman, P G Moorman, R Millikan, et al.
Pageof 6